lyophilization is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-06-16. Numbers and descriptions here follow the published literature rather than marketing material.
At the molecular level, ipamorelin acts as an agonist at the growth hormone secretagogue receptor type 1a, the same G protein-coupled receptor that binds ghrelin. Receptor activation couples to Gq/11 signaling, raising intracellular calcium through inositol trisphosphate and diacylglycerol, which in turn promotes exocytosis of growth hormone from pituitary somatotroph cells. Ipamorelin binds this receptor with high affinity and shows weak activity at other secretagogue-related targets in vitro. Its action requires the intact receptor and is not reversed by growth hormone-releasing hormone antagonists.
Compared with earlier growth hormone secretagogues such as GHRP-6 and hexarelin, ipamorelin has been reported to produce less stimulation of adrenocorticotropic hormone, cortisol, and prolactin in animal and early human studies. This selectivity is usually attributed to differences in receptor subtype interactions and to the tissue distribution of the receptor. Effects on appetite appear weaker than those of ghrelin itself, although the supporting evidence base is small. Whether these differences produce a distinct clinical profile remains an open question, since controlled human trials are limited.
Ipamorelin is a synthetic pentapeptide first described in the 1990s by researchers at Novo Nordisk during a program to develop selective growth hormone secretagogues. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, incorporating two non-natural residues, alpha-aminoisobutyric acid and D-2-naphthylalanine. The C-terminus is amidated, and the material is supplied as a white lyophilized powder. The molecular formula is C38H49N9O5 and the monoisotopic mass is approximately 711.85 daltons. The short chain and modified residues give it greater resistance to enzymatic degradation than many larger peptide hormones.
Ipamorelin is a synthetic pentapeptide that acts on the growth hormone secretagogue receptor, also known as the ghrelin receptor. Its sequence contains five amino acid residues, including a non-natural residue that increases stability against enzymatic breakdown. The compound was developed in the 1990s as part of research into small peptides that stimulate pituitary hormone release. Unlike larger protein hormones, it can be produced by solid-phase peptide synthesis and characterized by standard analytical methods.
At the receptor level, ipamorelin binds GHS-R1a and triggers signaling through Gq-coupled pathways. Activation leads to calcium release and downstream effects in pituitary somatotroph cells. These events promote the release of growth hormone into circulation. The response depends on the presence of the receptor and on the physiological state of the animal or tissue studied. Because the receptor is also found in other tissues, effects beyond the pituitary have been examined in laboratory models, though the extent of those effects remains an area of ongoing study.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C38H49N9O5 | Pentapeptide with amidated C-terminus |
| Molecular weight | 711.85 g/mol | Monoisotopic mass |
| Primary receptor | GHS-R1a | Ghrelin receptor, Gq/11 coupled |
| Peptide class | Synthetic pentapeptide | Contains two non-natural residues |
| Reported selectivity | Lower cortisol and prolactin effect | Observed in animal and early human work |
Identity and purity assessment of ipamorelin relies mainly on reversed-phase high-performance liquid chromatography with ultraviolet detection near 214 nanometers, a wavelength where the peptide backbone absorbs. Mass confirmation is typically obtained by electrospray ionization mass spectrometry or by liquid chromatography coupled to mass spectrometry, comparing the observed mass with the calculated value. Amino acid analysis and peptide mapping after enzymatic digestion can confirm the sequence. Impurity profiles include deletion peptides, truncated fragments, and oxidation products, reported as relative area percentages.
Lyophilized ipamorelin is generally held at minus twenty degrees Celsius or colder, protected from light and moisture. In solution the peptide is less stable, and degradation proceeds through hydrolysis of the amide backbone, oxidation of the histidine residue, and aggregation. Repeated freeze-thaw cycles accelerate these processes, so dividing material into single-use aliquots before freezing is common practice in research settings. Buffered formulations near neutral pH tend to show the slowest degradation, while strongly acidic or basic conditions raise hydrolysis rates. Stability data specific to ipamorelin are sparse, and much guidance is extrapolated from other short peptides.
Quality control for research-grade ipamorelin is not governed by a single harmonized pharmacopeial monograph, so certificates of analysis vary between suppliers. Common tests include appearance, solubility, water content, peptide content by quantitative amino acid analysis, and residual counterion measurement. Independent verification by an outside laboratory is often used to confirm identity and purity claims. Salt form, counterion content, and residual solvent levels are frequently unspecified, which complicates direct comparison between lots and leaves reproducibility partly unresolved.
Peptides such as ipamorelin are subject to chemical and physical degradation. Hydrolysis of peptide bonds, oxidation of susceptible residues, and aggregation are common pathways that reduce purity over time. The rate of these processes depends on temperature, moisture, pH, and the number of freeze-thaw cycles a sample undergoes. Because the compound is typically handled as a lyophilized powder, controlling moisture during storage is a central concern. Degradation products can be detected with separation techniques that resolve the parent peptide from related impurities.
Lyophilized material is generally stored frozen and protected from light and moisture. Typical recommendations place dry powder at temperatures well below freezing, while reconstituted solutions are kept cold and used within a defined window. Repeated freezing and thawing should be avoided because it can promote aggregation and loss of material. The choice of solvent matters as well; compatibility with the intended diluent should be checked before preparation. These handling practices aim to preserve both the quantity and the integrity of the peptide.
Activity is mediated mainly through the growth hormone secretagogue receptor, now generally called the ghrelin receptor or GHS-R1a. Binding at this G-protein-coupled receptor triggers phospholipase C signaling, calcium mobilization, and release of growth hormone from pituitary somatotrophs. Reports describe less pronounced stimulation of adrenocorticotropic hormone and prolactin compared with earlier secretagogues such as hexarelin or GHRP-6. Selectivity figures vary between assay systems, so the degree of separation from other secretagogues is an area of ongoing comparison rather than a fixed constant.
In animal and early human studies, ipamorelin produces pulsatile growth hormone release and a secondary rise in insulin-like growth factor 1. The magnitude and duration of that rise depend on route, sampling schedule, and the baseline endocrine state of the subject. Whether repeated exposure alters the response over time is not firmly settled, since some reports describe stable pulsatility while others note attenuation. Most published data come from small samples, which limits the strength of any general claim about long-term behavior.
从用途定位看，ipamorelin 目前主要以研究用肽的身份被讨论，未见主要药品监管机构将其批准为治疗药物。市售材料通常标注仅供研究使用，不得用于人体或诊断程序。文献中它常与生长激素促分泌素、GHS-R1a 激动剂、胃饥饿素拟似物等表述并列出现。既有研究的样本量普遍偏小，因此对其效应强度与一致性的描述应保持谨慎。
Ipamorelin 是一种合成五肽，序列为 Aib-His-D-2-Nal-D-Phe-Lys-NH2，分子式 C38H49N9O5，游离碱分子量约 711.85 g/mol。它属于生长激素促分泌素（GHS）家族，作用靶点是胃饥饿素受体 GHS-R1a。该化合物由诺和诺德的研究团队在二十世纪九十年代末报道，设计目标是提高对生长激素释放的选择性。C 端酰胺化与 N 端 Aib 残基是两个用于抵抗肽酶降解的结构特征。
在 GHS 家族中，早期肽类如 GHRP-6 与 GHRP-2 会同时促进生长激素、皮质醇与催乳素的释放，并明显增加食欲。Ipamorelin 在动物与早期人体研究中表现出对生长激素释放的相对选择性，对上述其他激素的影响较小。这种差异通常归因于受体结合模式与下游信号偏向的不同，而完整的分子解释仍有待补充。需要区分的是，选择性是研究观察中的相对程度，并非绝对界限。
As a social institution, chattel slavery classes slaves as chattels (personal property) owned by the enslaver; like livestock, they can be bought and sold at will. Chattel slavery was historically a widely accepted form of slavery in many parts of the world, and was practiced in places such as ancient Greece and the Roman Empire, where it was considered a keystone of society. Other examples include the institution of slavery in the Muslim world such as Medieval Egypt, as well as Sub-Saharan Africa, Brazil, the Antebellum United States, and parts of the Caribbean such as Cuba and Haiti. The Iroquois also had practices similar to chattel slavery; the key difference was that captives were held for the stated purpose of "assimilating them into Iroquoian culture". As a result, there were several ways to escape captivity, and the children of those in bondage "became fully part of society". Beginning in the 18th century, a series of abolitionist movements in Europe and the Americas saw slavery as a violation of the slaves' rights as people ("all men are created equal"), and sought to abolish it. Abolitionism encountered extreme resistance but was eventually successful. Several of the states of the United States began abolishing slavery during the American Revolutionary War. After the French Revolution, the government of France abolished slavery in 1794, but Napoleon reintroduced it in 1802 and permanent abolition did not occur until 1848.
== Named after Dyson == Dyson conjecture Dyson equation Dyson numbers Dyson operator Dyson series Dyson sphere Dyson tree Dyson's crank Dyson's eternal intelligence Dyson's transform Dyson–Maleev spin wave theory Schwinger–Dyson equation Thue–Siegel–Dyson–Roth theorem Feynman diagram, also known as Dyson graphs Wigner–Yamase–Dyson conjecture Gordon Freeman, a fictional character named after Dyson
===== MeSH D08.811.682.690 – oxygenases ===== MeSH D08.811.682.690.416 – dioxygenases MeSH D08.811.682.690.416.277 – catechol 1,2-dioxygenase MeSH D08.811.682.690.416.305 – catechol 2,3-dioxygenase MeSH D08.811.682.690.416.319 – cysteine dioxygenase MeSH D08.811.682.690.416.326 – homogentisate 1,2-dioxygenase MeSH D08.811.682.690.416.328 – 3-hydroxyanthranilate 3,4-dioxygenase MeSH D08.811.682.690.416.330 – 4-hydroxyphenylpyruvate dioxygenase MeSH D08.811.682.690.416.333 – indoleamine-pyrrole 2,3-dioxygenase MeSH D08.811.682.690.416.444 – lipoxygenase MeSH D08.811.682.690.416.444.050 – arachidonate lipoxygenases MeSH D08.811.682.690.416.444.050.055 – arachidonate 5-lipoxygenase MeSH D08.811.682.690.416.444.050.060 – arachidonate 12-lipoxygenase MeSH D08.811.682.690.416.444.050.065 – arachidonate 15-lipoxygenase MeSH D08.811.682.690.416.444.525 – protocatechuate 3,4-dioxygenase MeSH D08.811.682.690.416.722 – tryptophan oxygenase MeSH D08.811.682.690.562 – inositol oxygenase MeSH D08.811.682.690.708 – mixed function oxygenases MeSH D08.811.682.690.708.062 – benzoate 4-monooxygenase MeSH D08.811.682.690.708.125 – catechol oxidase MeSH D08.811.682.690.708.125.500 – monophenol monooxygenase MeSH D08.811.682.690.708.170 – cytochrome p-450 enzyme system MeSH D08.811.682.690.708.170.040 – aryl hydrocarbon hydroxylases MeSH D08.811.682.690.708.170.040.024 – 7-alkoxycoumarin o-dealkylase MeSH D08.811.682.690.708.170.040.050 – aniline hydroxylase MeSH D08.811.682.690.708.170.040.110 – benzopyrene hydroxylase MeSH D08.811.682.690.708.170.040.332 – cytochrome p-450 cyp1a1 MeSH D08.811.682.690.708.170.040.443 – cytochrome p-450 cyp1a2 MeSH D08.811.682.690.708.170.040.499 – cytochrome p-450 cyp2b1 MeSH D08.811.682.690.708.170.040.555 – cytochrome p-450 cyp2d6 MeSH D08.811.682.690.708.170.040.777 – cytochrome p-450 cyp2e1 MeSH D08.811.682.690.708.170.040.888 – cytochrome p-450 cyp3a MeSH D08.811.682.690.708.170.085 – camphor 5-monooxygenase MeSH D08.811.682.690.708.170.500 – alkane 1-monooxygenase MeSH D08.811.682.690.708.170.915 – steroid hydroxylases MeSH D08.811.682.690.708.170.915.050 – aldosterone synthase MeSH D08.811.682.690.708.170.915.099 – aromatase MeSH D08.811.682.690.708.170.915.200 – cholesterol 7 alpha-hydroxylase MeSH D08.811.682.690.708.170.915.212 – cholesterol side-chain cleavage enzyme MeSH D08.811.682.690.708.170.915.400 – 25-hydroxyvitamin d3 1-alpha-hydroxylase MeSH D08.811.682.690.708.170.915.720 – steroid 11-beta-hydroxylase MeSH D08.811.682.690.708.170.915.730 – steroid 12-alpha-hydroxylase MeSH D08.811.682.690.708.170.915.737 – steroid 16-alpha-hydroxylase MeSH D08.811.682.690.708.170.915.748 – steroid 17-alpha-hydroxylase MeSH D08.811.682.690.708.170.915.760 – steroid 21-hydroxylase MeSH D08.811.682.690.708.292 – dopamine beta-hydroxylase MeSH D08.811.682.690.708.392 – fatty acid desaturases MeSH D08.811.682.690.708.392.312 – beta-carotene 15,15'-monooxygenase MeSH D08.811.682.690.708.392.468 – Linoleoyl-CoA desaturase MeSH D08.811.682.690.708.392.625 – stearoyl-coa desaturase MeSH D08.811.682.690.708.401 – gamma-butyrobetaine dioxygenase MeSH D08.811.682.690.708.410 – heme oxygenase (decyclizing) MeSH D08.811.682.690.708.410.500 – heme oxygenase-1 MeSH D08.811.682.690.708.425 – 4-hydroxybenzoate 3-monooxygenase MeSH D08.811.682.690.708.557 – kynurenine 3-monooxygenase MeSH D08.811.682.690.708.601 – phenylalanine hydroxylase MeSH D08.811.682.690.708.660 – procollagen-lysine, 2-oxoglutarate 5-dioxygenase MeSH D08.811.682.690.708.673 – procollagen-proline dioxygenase MeSH D08.811.682.690.708.715 – prostaglandin-endoperoxide synthases MeSH D08.811.682.690.708.749 – squalene monooxygenase MeSH D08.811.682.690.708.783 – steroid hydroxylases MeSH D08.811.682.690.708.783.050 – aldosterone synthase MeSH D08.811.682.690.708.783.099 – aromatase MeSH D08.811.682.690.708.783.200 – cholesterol 7 alpha-hydroxylase MeSH D08.811.682.690.708.783.212 – cholesterol side-chain cleavage enzyme MeSH D08.811.682.690.708.783.400 – 25-hydroxyvitamin d3 1-alpha-hydroxylase MeSH D08.811.682.690.708.783.720 – steroid 11-beta-hydroxylase MeSH D08.811.682.690.708.783.730 – steroid 12-alpha-hydroxylase MeSH D08.811.682.690.708.783.737 – steroid 16-alpha-hydroxylase MeSH D08.811.682.690.708.783.745 – steroid 17-alpha-hydroxylase MeSH D08.811.682.690.708.783.760 – steroid 21-hydroxylase MeSH D08.811.682.690.708.826 – trans-cinnamate 4-monooxygenase MeSH D08.811.682.690.708.870 – tryptophan hydroxylase MeSH D08.811.682.690.708.923 – tyrosine 3-monooxygenase
Sources: en.wikipedia.org
As Russia regained stability, discontent grew within the serf and peasant populations. Under Alexis Romanov, Mikhail's son, the Code of 1649 divided the Russian population into distinct and fixed hereditary categories. The Code increased tax revenue for the central government and put an end to nomadism, to stabilize the social order by fixing people on the same land and in the same occupation as their families. Peasants were tied to the land, and townsmen were forced to take on their fathers' occupations. The increased tax burden fell mainly on the peasants, further widening the gap between the poor and wealthy. Human and material resources became limited as the government organized more military expeditions, putting even greater strain on the peasants. War with Poland and Sweden in 1662 led to a fiscal crisis, and rioting across the country. Taxes, harsh conditions, and the gap between social classes drove peasants and serfs to flee. Many went to the Cossacks, knowing that the Cossacks would accept refugees and free them. The Cossacks experienced difficulties under Tsar Alexis as more refugees arrived daily. The Tsar gave the Cossacks a subsidy of food, money, and military supplies in return for acting as border defense. These subsidies fluctuated often; a source of conflict between the Cossacks and the government. The war with Poland diverted necessary food and military shipments to the Cossacks as fugitive peasants swelled the population of the Cossack host.
==== Electronics ==== Because of low density and good mechanical and electrical properties, magnesium is used for manufacturing of mobile phones, laptop and tablet computers, cameras, and other electronic components. It was used as a premium feature because of its light weight in some 2020 laptops.
11-Hydroxy-Δ9-tetrahydrocannabinol (11-OH-Δ9-THC, alternatively numbered as 7-OH-Δ1-THC), usually referred to as 11-hydroxy-THC within cannabis culture, is the main active metabolite of tetrahydrocannabinol (THC), the major psychoactive substance in cannabis. After cannabis consumption, THC is metabolized inside the body by cytochrome P450 enzymes such as CYP2C9 and CYP3A4 into 11-hydroxy-THC and then further metabolized by dehydrogenase and CYP2C9 enzymes to form 11-nor-9-carboxy-THC (THC-COOH), which is inactive at the CB1 receptors; and further glucuronidated to form 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid glucuronide (Δ9-THC-COOH-glu) in the liver, from where it is subsequently excreted through feces and urine. Both metabolites can be assayed in drug tests. 11-hydroxy-THC is formed after human consumption of THC containing products regardless of administration route, although levels of 11-hydroxy-THC are typically higher when cannabis products are eaten instead of inhaled.
Sources: en.wikipedia.org
=== Structure of Green EosFP === In its anionic form, the green chromophore has an absorption maxima at 506 nm and an emission maxima at 516 nm. It is formed autocatalytically from amino acids His-62, Tyr-63 and Gly-64. Immediately surrounding the chromophore there is a cluster of charged or polar amino acids as well as structural water molecules. Above the plane of the chromophore, there is a network of hydrogen bond interactions between Glu-144, His-194, Glu-212 and Gln-38. Arg-66 and Arg-91 participate in hydrogen bonding with the carbonyl oxygen of green Eos's imidazolinone moiety. The His-62 side chain lies in an unpolar environment. Conversion from the green to red form depends on the presence of a histidine in the first position of the tripeptide HYG that forms the chromophore. When this histidine residue is substituted with M, S, T or L, Eos only emits bright green light and no longer acts as a photoconvertible fluorescent protein.
Herophilos (335–280 BC) described the functions of the optic nerve in sight and the oculomotor nerve in eye movement. Analysis of the nerves in the cranium enabled him to differentiate between blood vessels and nerves (Ancient Greek: νεῦρον (neûron) "string, plant fiber, nerve"). Modern research has not confirmed William Cullen's 1785 hypothesis associating mental states with physical nerves, although popular or lay medicine may still invoke "nerves" in diagnosing or blaming any sort of psychological worry or hesitancy, as in the common traditional phrases "my poor nerves", "high-strung", and "nervous breakdown".
== Side effects == Benzydamine is well tolerated. Occasionally oral tissue numbness or stinging sensations may occur, as well as itching, a skin rash, skin swelling or redness, difficulty breathing and wheezing.
Sources: en.wikipedia.org
It is a synthetic pentapeptide belonging to the growth hormone secretagogue family. Its principal characterized target is the ghrelin receptor, also called GHS-R1a. The molecule contains non-natural amino acids and an amidated C-terminus.
Both act at the same G protein-coupled receptor, but ipamorelin is a short synthetic peptide with modified residues rather than the natural 28-amino-acid hormone. Reports describe weaker effects on appetite and on cortisol or prolactin release than those seen with ghrelin. Its resistance to enzymatic breakdown also differs from that of the natural ligand.
Receptor binding and downstream calcium signaling are well characterized in cell-based systems. Effects measured in whole organisms are less consistent across studies and species. The extent to which selective receptor behavior drives the observed hormonal profile is still debated.
It acts on the growth hormone secretagogue receptor, GHS-R1a, which is also the receptor for ghrelin. Binding triggers intracellular signaling that promotes growth hormone release from the pituitary. The interaction is the basis for its classification as a secretagogue.